Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study

BACKGROUND: Novel therapies often fail to reach the bedside due to low trial recruitment rates. Prior to conducting one of the first chimeric antigen receptor (CAR) T cell therapy trials in Canada, we used the Theoretical Domains Framework, a novel tool for identifying barriers and enablers to behav...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, Gisell, Lalu, Manoj, Asad, Sarah, Foster, Madison, Kekre, Natasha, Fergusson, Dean, Hawrysh, Terry, Atkins, Harold, Thavorn, Kednapa, Montroy, Joshua, Schwartz, Stuart, Holt, Robert, Broady, Raewyn, Presseau, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995587/
https://www.ncbi.nlm.nih.gov/pubmed/33766105
http://dx.doi.org/10.1186/s13063-021-05121-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995587/
https://www.ncbi.nlm.nih.gov/pubmed/33766105
http://dx.doi.org/10.1186/s13063-021-05121-y

Ejemplares similares